Central serous retinopathy (CSR) is an eye disease where fluid collects under the central part of the retina and makes central vision blurry or distorted. It usually affects one eye at a time and often happens in stressed, middle-aged people, especially men. It is usually temporary, but it can come back or become long-lasting in some people. NCBI+1
Central serous retinopathy (CSR), also called central serous chorioretinopathy (CSCR), is an eye disease where fluid leaks under the retina, usually under the macula, the part that gives sharp central vision. This trapped fluid makes a small “bubble” that blurs or distorts central vision, often in one eye, but sometimes in both.NCBI+1
CSR is strongly linked with stress, high levels of the hormone cortisol, and use of steroid medicines (tablets, injections, inhalers, nasal sprays, or skin creams). It is more common in men aged about 30–50 and in people with high-pressure, “Type A” personalities, high blood pressure, sleep apnea, or Cushing’s syndrome.AAO+3AAO Journal+3EyeWiki+3
In many people, acute CSR goes away by itself within 3–4 months and vision improves. But in chronic CSR, the fluid lasts longer, can come back many times, and may slowly damage the retina and cause permanent vision changes if not treated. Modern reviews suggest half-dose or half-fluence photodynamic therapy (PDT) with verteporfin is the most effective active treatment for chronic CSR.Wikipedia+3PMC+3AAO Journal+3
Other names of central serous retinopathy
Central serous retinopathy has a few other names that doctors and researchers use. The most common medical name today is central serous chorioretinopathy (CSC or CSCR). The word “choroid” is added because the problem starts from the blood vessels in the choroid, the layer under the retina. Older textbooks may call it central serous retinopathy (CSR) or central serous maculopathy (CSM), because it mainly affects the macula, the sharp-vision area in the center of the retina. All these names describe the same basic disease: a pocket of fluid under the central retina due to a leak through the retinal pigment epithelium (RPE). NCBI+1
Types of central serous retinopathy
In simple terms, doctors divide CSR/CSC into a few main types based on how long it lasts and what the scans show.
The first main type is acute central serous retinopathy. In this type, the symptoms are new (often a few days or weeks), and the fluid under the retina usually goes away by itself within 3–6 months. Most people with this acute type get almost full vision back without treatment, so doctors often just watch and wait. However, during this time, vision can be blurry, distorted or washed out, which can be very disturbing to the patient. NCBI+1
The second important type is chronic central serous retinopathy. Here, the fluid under the retina stays for more than 3–6 months or keeps coming back frequently. The retina and RPE can become scarred or thinned, and this may cause permanent loss of contrast sensitivity and sharp vision, even if the fluid later disappears. Chronic CSR is more serious and often needs active treatment, such as laser or photodynamic therapy, to try to stop the leak and protect the macula. NCBI+1
Another way to classify the disease is into focal and diffuse types. In focal disease, there is a small, clearly defined leaking spot in the RPE that can be seen on fluorescein angiography. In diffuse disease, the leakage is spread over a wider area, with many small leaks or a broad leak, and the RPE is more widely damaged. Diffuse disease usually behaves more like chronic CSR and has a higher risk of long-term vision changes. Retina Today+1
Doctors also speak about primary (idiopathic) CSR and secondary CSR-like detachments. Primary or idiopathic CSR means there is no other main eye disease, and it occurs by itself, although risk factors like stress and steroids are often present. Secondary CSR-like fluid can happen in other conditions, such as steroid-induced eye changes, Cushing syndrome, or after some eye surgeries. In these secondary cases, the fluid and leakage look similar to regular CSR, but they are driven by another underlying systemic or eye problem. NCBI+1
Some specialists now group CSR inside a family called pachychoroid disorders. These are conditions where the choroid (the blood vessel layer under the retina) is abnormally thick and leaky. CSR is thought to be on the milder side of this spectrum. This idea helps explain why many people with CSR have a thick, congested choroid on special OCT scans and why treatments that reduce choroidal leakage, like photodynamic therapy, can help. NCBI+1
Causes and risk factors
CSR does not have one simple cause. It is usually the result of several risk factors acting together. These factors change the choroidal blood flow and damage the RPE barrier, allowing fluid to leak under the retina. NCBI+1
-
Psychological stress and “Type A” personality
Many patients with CSR report high life stress, anxiety, or a very driven “Type A” personality. Stress hormones like cortisol and adrenaline can affect blood vessels and the RPE, making leaks more likely. Studies have found a strong link between stress, certain personality traits, and CSR, although not everyone with stress gets the disease. EyeWiki+1 -
Use of corticosteroid medicines
Steroid medicines, taken by mouth, injected, inhaled, on the skin, or even in the nose, are one of the best-proven triggers of CSR. Steroids can thicken the choroid and change the behavior of RPE cells, making them more likely to leak. CSR has been reported even with relatively low doses of steroids and in people using them for skin, joint, or breathing problems. www.elsevier.com+1 -
Cushing syndrome and high cortisol levels
People whose bodies naturally produce too much cortisol, such as in Cushing syndrome, have a higher risk of CSR. Constant high cortisol acts like long-term steroid treatment and can damage the choroidal vessels and RPE, leading to fluid build-up under the retina. NCBI+1 -
Male sex
CSR is much more common in men than in women, especially in middle age. Researchers think this may be related to differences in hormones, lifestyle stress, and possibly genetic factors, but the exact reason is still unclear. MedEdu Journals+1 -
Middle age (30–60 years)
CSR most often appears in adults between 30 and 60 years old. At this age, many people are under work and family stress, and subtle changes in blood vessels and hormones may make the choroid and RPE more vulnerable to leakage. CSR is unusual in children and older elderly people. NCBI+1 -
Hypertension (high blood pressure)
High blood pressure can damage small blood vessels all over the body, including those in the choroid. When these vessels become stiff and leaky, it is easier for fluid to seep through the RPE, increasing the chance of CSR. Several studies show hypertension is more frequent in people with CSR than in the general population. ScienceDirect+1 -
Sleep problems and sleep apnea
Poor sleep quality and obstructive sleep apnea are linked with CSR. Repeated drops in oxygen and surges of stress hormones during the night may strain choroidal vessels and the RPE, opening the door to subretinal fluid. ScienceDirect+1 -
Pregnancy
CSR can happen during pregnancy, usually in the third trimester. In pregnancy, hormone levels, blood volume, and blood pressure fluctuate, and these changes may stress the choroidal circulation. Fluid often resolves after delivery, but eye follow-up is needed. www.elsevier.com+1 -
Use of sympathomimetic drugs
Medicines that mimic adrenaline, such as some decongestants, asthma drugs, or stimulants, can narrow and then dilate blood vessels and raise blood pressure. These effects may disturb choroidal blood flow and increase the risk of CSR in susceptible people. www.elsevier.com+1 -
Alcohol use
Some studies suggest that heavy alcohol use is more common in people with CSR. Alcohol can affect the liver, hormones, and blood pressure, and may indirectly disturb choroidal circulation, though this link is not as strong as steroids or stress. www.elsevier.com+1 -
Helicobacter pylori infection
Helicobacter pylori is a stomach bacterium that can cause ulcers. Research has found a higher rate of H. pylori infection in patients with CSR compared with controls. The infection may cause systemic inflammation or immune responses that affect choroidal vessels, but this connection is still being studied. PMC+1 -
Acid peptic disease and reflux
People with acid peptic disease, such as gastric ulcers or reflux, are over-represented in some CSR studies. This may be due to underlying inflammation, certain medications, or shared risk factors like stress and smoking. ResearchGate+1 -
Use of certain other medicines
Besides steroids, other medicines such as some antidepressants, antibiotics, and erectile dysfunction drugs have been reported in association with CSR in case reports. The exact mechanisms are unclear, but they may act through blood pressure, vascular changes, or hormonal effects. JCPSP+1 -
Autoimmune and inflammatory diseases
Some autoimmune or inflammatory conditions are associated with CSR. Chronic inflammation can alter the choroidal blood vessels and RPE, making them more permeable. However, it can be hard to separate the effect of the disease itself from the effect of steroid treatment, which is a known trigger. ScienceDirect+1 -
Pachychoroid (thick choroid)
Many CSR patients have a naturally thick choroid on enhanced-depth OCT imaging. A thick, congested choroid can increase pressure against the RPE, creating weak spots where fluid can leak through. This structural feature is a key part of the modern understanding of CSR. NCBI+1 -
Genetic predisposition
Some families show more cases of CSR, suggesting a genetic tendency. Small genetic variations may affect choroidal vessels, stress hormone receptors, or RPE function, making some people more prone to the disease. Research is ongoing to discover the exact genes involved. ResearchGate+1 -
Smoking
Smoking damages blood vessels and raises oxidative stress. These effects can harm choroidal capillaries and the RPE, possibly increasing the risk of CSR and making recovery slower, although the evidence is weaker than for steroids and stress. MedEdu Journals+1 -
Helicopter-type or high-pressure work environments (possible)
Some reports mention CSR in people with very demanding jobs, such as pilots, executives, and emergency workers. This may not be due to the job itself, but to high stress, irregular sleep, and sometimes steroid use. It highlights how lifestyle and occupational stress can interact with eye health. EyeWiki+1 -
Previous episode of CSR
Having CSR once is a risk factor for getting it again. Recurrences can happen in 30–50% of patients over time, often triggered by new stress or steroid exposure. Each new episode raises the chance of chronic changes in the macula. PMC+1 -
Unknown or idiopathic factors
In many patients, no clear risk factor is found. In these idiopathic cases, there may be subtle combinations of genetics, mild stress, small hormone changes, or unrecognized environmental factors that current research cannot fully measure yet. NCBI+1
Symptoms
CSR mostly affects central vision in one eye, and symptoms can appear suddenly or over a few days. Retina Today+1
-
Blurred central vision
The most common symptom is a blurry spot right in the center of what you are looking at. Words on a page may appear soft, and faces may not look sharp. This happens because the macula is lifted by fluid, so light does not focus correctly on the photoreceptors. -
Gray or dark spot in the center (central scotoma)
Some people notice a gray, dark, or washed-out patch in the middle of their vision. This “missing” area makes it hard to see fine details, read small print, or recognize faces. -
Straight lines look bent or wavy (metamorphopsia)
Lines on a grid or the edge of a doorframe may look curved, wavy, or distorted. This distortion is because the layer of photoreceptors is uneven due to the bubble of fluid under the retina. AAO+1 -
Objects look smaller than usual (micropsia)
Things you look at may appear smaller or further away in the affected eye. This size change occurs when the retina is stretched or the photoreceptor spacing is altered over the fluid pocket. Retina Today+1 -
Colors look dull or washed out
Colors may seem less bright, and there may be a slight yellow, gray, or brown tint to what you see. The layer that senses color is disturbed, so the brain receives weaker color information. AAO+1 -
Reduced contrast sensitivity
Fine differences between light and dark areas are harder to see. For example, reading light gray text on a white background may feel unusually difficult. This can remain even after the fluid appears to have cleared. Retina Today+1 -
Difficulty reading
Because the central part of vision is affected, reading small print becomes slow and tiring. People may find themselves skipping letters or needing brighter light and more time to read. -
Trouble with near work or detailed tasks
Tasks like sewing, drawing, or using a smartphone may be hard because they depend heavily on sharp central vision. People may avoid these activities or feel eye strain when they try. -
Straight-ahead vision worse than side (peripheral) vision
Peripheral vision usually stays normal. This can feel strange, because you may see movement and large shapes fine, but you cannot see someone’s face clearly when you look directly at them. -
Change in depth perception
With one eye seeing blurred or distorted images, judging distances becomes harder. Pouring liquids, climbing stairs, or parking a car can feel slightly off or uncomfortable. -
Headache or eye strain
Some people develop headaches or a feeling of strain around the eyes. This often happens because the brain is trying to combine a clear image from one eye with a blurred image from the other, which takes extra effort. -
Sensitivity to bright light
Bright lights or glare may bother the affected eye more than usual. The swollen macula and altered retinal layers can change how light is processed, making bright light feel harsh. -
Slow recovery of vision after looking at bright light
After looking at something very bright, such as a phone screen or sunlight, the affected eye may take longer to “recover” a clear image. This is due to the impaired function of photoreceptors sitting over fluid. -
Symptoms worse in low light
Some people find it harder to see clearly in dim conditions, like at dusk or in a restaurant. The already stressed macula may struggle more in low light, when the eye demands extra sensitivity. -
Anxiety about vision changes
The sudden change in central vision often causes worry or fear about going blind. While most acute CSR cases improve, this emotional reaction is very real and may further increase stress, which is itself a risk factor. Many eye doctors therefore take time to reassure patients and explain the usual good prognosis. Dr Agarwals Eye Hospital+1
Diagnostic tests
Diagnosis of CSR uses a combination of clinical examination and specialized eye tests. These tests help confirm the presence of subretinal fluid, find the leak, and rule out other eye diseases. NCBI+1
Physical exam–based tests
-
General medical history and systemic review
The eye doctor asks about stress, medications (especially steroids), pregnancy, high blood pressure, sleep problems, and other illnesses. This simple conversation helps find risk factors and rule out other causes of retinal fluid, such as diabetes or inflammation. NCBI+1 -
Visual acuity testing
The doctor checks how well you can read letters on a chart with each eye separately. This measures how much the central vision is affected. In CSR, vision is often mildly to moderately reduced, such as from 6/6 (20/20) to 6/12 or 6/18, but it can be better or worse depending on the amount and location of fluid. NCBI+1 -
Amsler grid test
You look at a grid of straight lines, similar to graph paper. With CSR, the center of the grid may look distorted, wavy, or have a blank spot. This simple bedside test helps detect metamorphopsia and central scotoma and can be used at home to monitor changes. AAO+1 -
Pupil and color vision assessment
The doctor shines a light to see how the pupil reacts and may test color vision with color plates. This helps rule out optic nerve disease and other retinal conditions. In CSR, basic pupil responses are usually normal, but subtle color changes can be present. -
Blood pressure measurement
Because hypertension is a known risk factor, measuring blood pressure is part of a thorough evaluation. If high blood pressure is found, the patient may be referred to a general doctor for management, which can help reduce future risk of CSR. ScienceDirect+1
Manual / clinical eye examination
-
Slit-lamp biomicroscopy with dilated fundus exam
The ophthalmologist uses a slit-lamp microscope and dilating drops to look at the retina and macula in detail. In CSR, the doctor may see a round or oval area of shallow detachment in the macula that looks like a blister, sometimes with a small yellowish spot at the leak site. This exam is key to suspecting CSR. NCBI+1 -
Indirect ophthalmoscopy
With a special lens and head-mounted light, the retina is examined more widely, including the peripheral areas. This helps rule out retinal tears, tumors, or inflammation that could also cause fluid under the retina but are treated differently from CSR. -
Stereoscopic fundus photography
Photographs of the back of the eye can be taken in 3D style to document the fluid and macular changes. These images help follow the disease over time and compare before-and-after results if treatment is given.
Lab and pathological tests
-
Basic blood tests (full blood count, metabolic panel)
Simple blood tests may be ordered to rule out inflammatory, infectious, or systemic diseases that could mimic or worsen CSR. Although no blood test “proves” CSR, it is important to exclude conditions such as uncontrolled diabetes or severe infections in atypical cases. -
Hormone and cortisol tests
If the patient has signs of Cushing syndrome or is on long-term steroid treatment, doctors may order hormone tests to check cortisol levels. Abnormal results can guide changes in systemic therapy, which may reduce the risk or recurrence of CSR. NCBI+1 -
Tests for Helicobacter pylori (breath, blood, or stool tests)
Because H. pylori infection has been linked with CSR, some clinicians may order tests for this bacterium, especially in recurrent or stubborn cases with stomach symptoms. Treating H. pylori may possibly help in selected patients, although this is still debated. PMC+1
Electrodiagnostic tests
-
Electroretinography (ERG)
ERG measures the electrical response of the retina to light flashes. It is not routinely needed in simple CSR, but in unusual or chronic cases, it can show whether the retina’s light-sensing cells are still working well. This helps separate CSR from other retinal diseases that cause more general retinal damage. NCBI+1 -
Multifocal ERG
This special version of ERG can measure function in many small areas of the retina at once. In CSR, it may show reduced function in the macula, matching the area of fluid. This helps to quantify how much the disease has affected retinal performance. -
Electro-oculography (EOG)
EOG checks the health of the RPE layer by measuring electrical changes when the eyes move. In chronic CSR, EOG may show abnormal results, meaning the RPE is not working normally. This can support the diagnosis and help predict long-term outcomes.
Imaging tests
-
Optical coherence tomography (OCT)
OCT is a key test for CSR. It uses light waves to make cross-section pictures of the retina. In CSR, OCT clearly shows the “bubble” of subretinal fluid under the neurosensory retina, often with a small bump of the RPE called a pigment epithelial detachment (PED). OCT also helps to monitor whether the fluid is increasing, stable, or resolving over time. Springer Link+1 -
Enhanced-depth OCT of the choroid
Enhanced-depth imaging (EDI) OCT allows the doctor to see the choroid more clearly. Many CSR eyes have a thickened choroid with dilated vessels. This supports the idea that CSR is part of the pachychoroid spectrum and can help distinguish it from other macular diseases. NCBI+1 -
Fundus fluorescein angiography (FFA / FA)
In FA, a fluorescent dye is injected into a vein in the arm, and a special camera takes pictures as the dye passes through the retinal blood vessels. In CSR, FA usually shows one or more leaking spots where dye seeps under the retina, often in a “smoke stack” or “ink blot” pattern. This test confirms the source of the leak and guides treatment like laser therapy. Springer Link+1 -
Indocyanine green angiography (ICGA)
ICGA uses a different dye that highlights the choroidal circulation more than FA does. In CSR, ICGA often shows areas of choroidal hyperpermeability and congestion that match the leakage zones. This test is especially useful in chronic or atypical cases, and when planning photodynamic therapy to target choroidal abnormalities. Medical Science Monitor+1 -
OCT angiography (OCTA)
OCTA is a non-invasive imaging method that maps blood flow in the retina and choroid without dye injection. In CSR, OCTA can show changes in the choriocapillaris blood flow and help rule out choroidal neovascular membranes, which may require different treatment. It is increasingly used to complement FA and ICGA in CSR assessment. pubmed.ncbi.nlm.nih.gov+1 -
Autofluorescence imaging
Fundus autofluorescence uses the natural glow of lipofuscin in the RPE to show areas of health or damage. In CSR, autofluorescence can highlight zones where RPE cells are stressed, damaged, or have recovered after previous episodes. This helps map chronic changes and may predict where future leaks could occur. NCBI+1
Non-Pharmacological Treatments for Central Serous Retinopathy
These are things without medicines that can help reduce risk, support healing, or work together with medical/surgical treatments.
-
Observation (“watch and wait”)
In fresh, first-time CSR, many eye doctors simply watch and re-check for 3–4 months, because the fluid often goes away on its own and vision improves. During this time, doctors monitor your vision, and do OCT scans and eye exams. No active treatment avoids unnecessary risk from drugs or laser in cases that will naturally recover.NCBI+1 -
Stopping or lowering steroid medicines (under doctor supervision)
If CSR starts while someone is using steroids (for asthma, skin disease, allergies, etc.), doctors usually try to lower the dose or stop the steroid or switch to a safer alternative. Sudden self-stopping steroids is dangerous, so changes must be done by a doctor. Reducing steroid exposure often lets the leaking area calm down and the fluid slowly reabsorb.PubMed+2AAO Journal+2 -
Stress management and psychological support
CSR is strongly linked with chronic stress, anxiety, and “Type A” personality traits. Learning coping skills, doing relaxation exercises, and sometimes seeing a psychologist can help lower stress hormones like cortisol. Lower stress may decrease the chance of repeated CSR attacks and may support recovery, even though it is not a “quick fix.”Retina Today+3PMC+3ResearchGate+3 -
Healthy sleep and treating sleep apnea
Poor sleep and obstructive sleep apnea (OSA) are risk factors for CSR. Sleep apnea can cause big night-time blood pressure and oxygen swings that affect the eye’s circulation. Treating OSA (for example with CPAP) and keeping a regular sleep routine helps stabilize blood flow in the choroid and may lower CSR risk and recurrences.ResearchGate+2EyeWiki+2 -
Blood pressure control
High blood pressure can damage tiny blood vessels, including those under the retina. Keeping blood pressure in a healthy range with lifestyle (salt reduction, exercise, weight control) and, if needed, prescribed medicines may reduce risk of chronic or recurrent CSR and protect overall eye health.AAO Journal+2MedEdu Journals+2 -
Avoiding unnecessary stimulant medicines and energy drinks
Strong decongestants, some ADHD drugs, and high-caffeine energy drinks can raise blood pressure and stress hormone levels. Doctors sometimes recommend reducing or switching these if CSR is present. Less stimulant load means less vascular stress on the delicate choroidal vessels under the retina.Ophthalmology Retina+1 -
Avoiding anabolic steroids and bodybuilding hormones
Anabolic-androgenic steroids used for bodybuilding or performance are linked with CSR through their strong effect on cortisol and blood vessels. Stopping these substances under medical guidance removes a major trigger and reduces the risk of new fluid leaks under the retina.MedEdu Journals+1 -
Managing Cushing’s syndrome or other hormone disorders
If CSR is related to endogenous hypercortisolism (for example Cushing’s disease), treating the hormone problem itself (with endocrine and sometimes surgical treatment) is crucial. When cortisol levels come back towards normal, CSR often stabilizes or improves.PubMed+3Canadian Journal of Ophthalmology+3Nature+3 -
Work and screen-use adjustments
Long hours of intense, focused near work, especially in dark rooms with bright screens, can make CSR symptoms feel worse. Taking regular breaks, improving lighting, and sitting at a comfortable distance can reduce visual strain and help you notice changes early, though this doesn’t directly “cure” CSR.NCBI+1 -
Smoking cessation
Smoking can harm blood vessels and may worsen eye diseases. Quitting smoking improves blood flow and lowers oxidative stress throughout the body, including the retina, which may help reduce the likelihood of recurrent CSR and many other eye problems.JCPSP+2Retina Today+2 -
Limiting alcohol intake
Heavy alcohol use is associated with CSR and also raises blood pressure and damages the liver and blood vessels. For adults, keeping alcohol low and, for teens, avoiding it entirely helps lower multiple CSR risk factors and protects general health.Canadian Journal of Ophthalmology+2Retina Today+2 -
Healthy exercise routine
Regular moderate exercise (like walking, cycling, or swimming) helps control blood pressure, weight, blood sugar, and stress. These changes may indirectly lower CSR risk and support better retinal circulation. Extreme over-training or bodybuilding with steroids, however, can have the opposite effect.NCBI+2MedEdu Journals+2 -
Dietary changes for cardiovascular and metabolic health
A diet rich in vegetables, fruits, whole grains, and healthy fats supports the small blood vessels in the eye. Limiting salt, sugar, and ultra-processed foods can help control blood pressure and metabolic syndrome, both of which are associated with CSR risk.NCBI+2MedEdu Journals+2 -
Treating reflux and stomach problems when present
CSR is more common in people with peptic ulcers and reflux disease. Treating these conditions with lifestyle changes and doctor-prescribed medicines may improve overall stress and steroid use patterns (for example, fewer steroids for inflammation) and slightly reduce CSR risk.MedEdu Journals -
Treating Helicobacter pylori infection (case-dependent)
Some studies link H. pylori stomach infection with CSR. In selected patients, doctors may test for H. pylori and treat it with antibiotics if positive. This is still debated, but it may help in some chronic or recurrent cases, and it improves stomach health anyway.MedEdu Journals -
Psychotherapy or counseling for anxiety and depression
Because CSR can both cause and be triggered by emotional problems, counseling can be part of treatment. Therapy may help reduce anxiety, depression, and unhealthy coping habits, which in turn may reduce cortisol levels and prevent repeated CSR flares.PMC+2Lippincott Journals+2 -
Mindfulness, yoga, and relaxation techniques
Breathing exercises, mindfulness meditation, gentle yoga, and similar practices can help lower stress and support better sleep and mood. These approaches are safe, low-cost tools that fit alongside medical treatment and can be practiced daily.PMC+1 -
Regular follow-up with a retina specialist
Even if you feel okay, chronic CSR can quietly damage your retina. Regular exams, OCT scans, and vision tests allow your doctor to catch changes early and decide when active treatment like PDT or medicines is needed.NCBI+2PMC+2 -
Avoiding eye trauma and extreme sports without protection
Direct trauma to the eye is not a typical CSR cause, but any additional retinal damage in a vulnerable eye is bad. Wearing protective eyewear for risky sports lowers the chance of new problems on top of CSR. -
Education for you and your family
Understanding what CSR is, recognizing symptoms (like blurring, a dark spot, or straight lines looking bent), and knowing when to ask for help can prevent long delays in treatment. Educated patients usually get better and safer care.NCBI+1
Drug Treatments for Central Serous Retinopathy
⚠️ Important: Very few medicines are officially approved specifically for CSR. Most are off-label or treat complications. Doses below are typical adult examples from FDA labels or studies, not personal prescriptions. Always follow an eye specialist’s advice.
-
Eplerenone (Inspra – mineralocorticoid receptor antagonist)
Eplerenone blocks mineralocorticoid receptors and may reduce choroidal vessel leakage linked to cortisol signaling in CSR. Typical adult doses for approved uses like heart failure or hypertension start at 25 mg once daily, increasing to 50 mg once daily if potassium and kidney function allow.Nature+4FDA Access Data+4FDA Access Data+4 Common side effects include high potassium, low blood pressure, kidney issues, dizziness, and fatigue. Evidence now suggests its effect on CSR vision results is modest or uncertain, so many specialists use it carefully or prefer PDT.Frontiers+2Medwave+2 -
Spironolactone (Aldactone – mineralocorticoid receptor antagonist)
Spironolactone is another aldosterone-blocking drug that has been studied in CSR, with some reports of reduced subretinal fluid and choroidal thickness. Typical adult doses for approved uses (heart failure, hypertension, etc.) are 25–100 mg per day, adjusted by doctors.Nature+3FDA Access Data+3FDA Access Data+3 Side effects may include high potassium, breast tenderness/enlargement (gynecomastia), low blood pressure, menstrual changes, and fatigue. -
Verteporfin (Visudyne – photosensitizer used in PDT)
Verteporfin is a light-activated drug used in photodynamic therapy. It travels in the bloodstream, sticks to abnormal vessels, and is then activated by a special laser to seal leaky areas under the retina. Typical dose is 6 mg/m² IV infusion, followed by a low-energy laser to the leaking spot.Wikipedia+4FDA Access Data+4FDA Access Data+4 Side effects can include temporary photosensitivity (easy sunburn), infusion-site pain, and rare sudden vision drop. -
Ranibizumab (Lucentis – anti-VEGF)
Ranibizumab blocks vascular endothelial growth factor (VEGF), reducing leakage from abnormal vessels. It is FDA-approved for several retinal diseases such as age-related macular degeneration and retinal vein occlusion, typically 0.5 mg (0.05 mL) intravitreal injection once monthly for these conditions.FDA Access Data+1 In CSR, it is used mostly when there is secondary choroidal neovascularization or when PDT is not possible. Side effects include eye pain, floaters, inflammation, increased eye pressure, and very rare infection.Taylor & Francis Online -
Aflibercept (Eylea – anti-VEGF fusion protein)
Aflibercept is a fusion protein that traps VEGF and related factors, reducing vascular leakage. For approved retinal uses like macular degeneration and diabetic macular edema, a common adult regimen is 2 mg (0.05 mL) intravitreal injection every 4 weeks initially, then every 8 weeks.FDA Access Data+2FDA Access Data+2 In CSR, it’s mainly used when there is secondary neovascularization or when other treatments have failed. Side effects are similar to other intravitreal injections (eye pain, inflammation, pressure rise, rare infection). -
Bevacizumab (Avastin – anti-VEGF, off-label ocular use)
Bevacizumab is an anti-VEGF antibody approved for cancers, but widely used off-label as eye injections for several retinal diseases because it is less expensive. Typical intravitreal doses used by retina specialists are around 1.25 mg (0.05 mL), though this is not in the official cancer label. Side effects include risks related to injections and, rarely, systemic effects like high blood pressure or clotting.Taylor & Francis Online+1 -
Acetazolamide (carbonic anhydrase inhibitor)
Acetazolamide is a diuretic that changes fluid transport across tissues. In some small CSR studies, short-term oral acetazolamide helped subretinal fluid clear a bit faster. Typical adult doses for its approved uses (e.g., glaucoma, altitude sickness) are 250–500 mg two to four times daily, but CSR regimens vary. Side effects can include tingling of fingers and toes, fatigue, stomach upset, kidney stones, and altered taste.NCBI+1 -
Rifampin / RIFADIN (rifampin)
Rifampin is an antibiotic that also speeds up breakdown of steroids in the liver (a “CYP inducer”). In chronic CSR linked to steroids, small studies have tried rifampin to lower cortisol exposure. Approved adult doses for tuberculosis are usually 600 mg daily in combination with other drugs.FDA Access Data+1 Side effects include liver damage, many drug interactions, orange body fluids, and flu-like symptoms, so its use for CSR is experimental and must be very carefully supervised. -
Ketoconazole (azole antifungal)
Ketoconazole reduces steroid production by blocking adrenal enzymes. It has been tried in CSR to lower cortisol levels in selected cases. Doses for endocrine uses are often in the 200–400 mg/day range in adults, but it carries a serious risk of liver toxicity and strong drug interactions. Because of safety concerns, its role in CSR is limited and must be specialist-guided.Nature+1 -
Mifepristone (glucocorticoid receptor antagonist)
Mifepristone blocks cortisol at its receptor and is used in some patients with Cushing’s syndrome. By reducing cortisol effects, it may theoretically help CSR associated with hypercortisolism, although data are limited. Approved doses for Cushing’s syndrome can range from 300–1200 mg daily, adjusted by an endocrinologist. Side effects include fatigue, nausea, low potassium, and effects on the uterus in people who can become pregnant.JAMA Network+1 -
Selective serotonin reuptake inhibitors (SSRIs – e.g., sertraline)
SSRIs are antidepressants used for anxiety and depression. In CSR, they are sometimes prescribed not for the eye directly but to manage the strong psychological stress and anxiety that can worsen or follow CSR. Typical adult doses of sertraline, for example, start at 25–50 mg daily. Side effects can include nausea, sleep changes, and mood changes.Lippincott Journals+1 -
Anxiolytics (short-term anti-anxiety drugs)
Short-term use of certain anti-anxiety medications may be considered in very distressed CSR patients, but they must be used carefully because of dependence risk and drowsiness. The aim is to calm intense stress around the acute episode, not to treat the retina directly. Doctors choose type and dose depending on age, other medicines, and mental health.PMC+1 -
Blood pressure medicines (e.g., ACE inhibitors, ARBs, beta-blockers)
If CSR occurs in a patient with uncontrolled hypertension, doctors may start or adjust blood pressure drugs. These medicines don’t directly cure CSR, but they improve vascular health and may reduce repeated episodes linked with high blood pressure and stress responses.AAO Journal+1 -
Propranolol (beta-blocker) in selected cases
Propranolol reduces adrenaline effects and heart rate. In some reports, beta-blockers helped CSR patients with severe stress reactions or pregnancy-related CSR, but evidence is limited. Typical adult doses vary widely (for example, 10–40 mg, 2–3 times daily for some indications). Side effects include low blood pressure, slow heart rate, tiredness, and cold hands/feet.AAO Journal+1 -
Antacids and acid-suppressing drugs (for reflux-linked CSR)
Some CSR patients also have reflux or peptic ulcer disease. Proton pump inhibitors or H2 blockers may be used to treat these conditions, not CSR directly, but improving reflux can reduce overall stress and steroid use in some cases.MedEdu Journals -
Topical ocular NSAIDs (e.g., nepafenac, ketorolac eye drops – off-label)
Some retina specialists may try non-steroidal anti-inflammatory eye drops to reduce inflammation and macular edema in complex cases. Evidence in CSR is limited, and these drugs mainly provide supportive control of inflammation. Side effects can be burning, irritation, and rare corneal problems if used too long.Frontiers+1 -
Oral antioxidants and multivitamins
Although not a core treatment, some doctors suggest antioxidant combinations similar to those used for macular degeneration (vitamins C, E, zinc, copper, lutein, etc.). They support retinal health but have no strong proof that they prevent CSR by themselves.Frontiers+1 -
Statins (cholesterol-lowering drugs) in selected cases
Statins improve endothelial function and reduce vascular inflammation. For adults with CSR and high cholesterol, a statin might be started mainly for heart protection; any possible CSR benefit is still under study. Side effects include muscle aches and rare liver issues.Frontiers+1 -
Anti-inflammatory drugs in clinical trials
Because recent research links inflammation to CSR, some trials are testing drugs that target specific inflammatory pathways. These are research-only and not standard care yet, but they may become part of future CSR treatment options.Frontiers+1 -
Experimental hormone-modulating drugs
Other medicines that modify steroid or sex-hormone pathways are under investigation in small studies, especially for recurrent CSR strongly linked to hormone imbalances. These drugs are not routine and must only be used in controlled research or under highly specialized supervision.ScienceDirect+2Springer Link+2
Dietary Molecular Supplements
Again, these do not replace medical or surgical treatment, but they may support general retinal and cardiovascular health. Always ask a doctor before starting supplements.
-
Lutein and zeaxanthin – Pigments that concentrate in the macula and help protect the retina from blue light and oxidative damage. Typical adult doses in eye-health formulas are around 10 mg lutein + 2 mg zeaxanthin daily. They may improve overall macular resilience but are not proven to directly cure CSR.Frontiers+1
-
Omega-3 fatty acids (EPA/DHA) – Found in fatty fish and fish-oil supplements, omega-3s support blood vessel health and reduce inflammation. Common adult supplement doses are 1000–2000 mg EPA+DHA per day. They may help general eye and heart health, indirectly supporting recovery.Frontiers+1
-
Vitamin C – A strong antioxidant that helps protect blood vessels and connective tissue. Typical adult supplemental doses range from 250–1000 mg daily. It supports collagen and capillary health in the retina, but excess doses can cause stomach upset or kidney stone risk in some people.Frontiers
-
Vitamin E – Fat-soluble antioxidant that protects cell membranes from oxidative damage. Eye-health formulas often use 200–400 IU per day for adults, but very high long-term doses may have risks, so dosing must be doctor-guided.Frontiers+1
-
Zinc – Important for retinal metabolism and antioxidant enzymes. Typical doses in eye formulas are 20–40 mg elemental zinc daily. Too much zinc can cause nausea and interfere with copper, so it’s usually combined with copper and taken under professional advice.Frontiers
-
Astaxanthin – A powerful carotenoid antioxidant found in algae and seafood. Common supplemental doses for adults are 4–12 mg daily. It may help reduce oxidative stress and improve microcirculation, but specific CSR data are limited.Frontiers
-
Coenzyme Q10 (CoQ10) – Helps mitochondrial energy production and acts as an antioxidant. Typical doses are 100–300 mg daily. By supporting energy use in retinal cells and vascular endothelium, CoQ10 may contribute to overall eye health.Frontiers
-
Curcumin – Anti-inflammatory compound from turmeric. Supplemental doses often range from 500–1000 mg per day (often with piperine to improve absorption). It may reduce systemic inflammation and oxidative stress that can affect choroidal vessels, though CSR-specific proof is still limited.Frontiers
-
Resveratrol – A polyphenol found in grapes and berries with antioxidant and vascular effects. Typical supplement doses are 100–500 mg daily. It may improve endothelial function and protect microvasculature, but evidence in CSR is still emerging.Frontiers+1
-
Ginkgo biloba extract – May increase blood flow and act as an antioxidant. Adult doses are often 120–240 mg/day in divided doses. It has potential interactions (for example, with blood thinners), so must be used carefully and only with doctor approval.Frontiers
Regenerative / Stem-Cell / “Immunity-Boosting Drugs
For CSR, no stem cell or regenerative drug is currently standard care or FDA-approved specifically for this disease. Research is ongoing, but it’s important to avoid false promises.
-
Experimental intravitreal stem-cell therapies
Researchers are exploring retinal and RPE (retinal pigment epithelium) cell-based therapies for several macular diseases. For CSR, these approaches aim to replace or support damaged RPE and improve subretinal fluid handling. These are only available in carefully controlled clinical trials; doses and protocols are experimental, not for routine use.Frontiers+1 -
Gene-therapy approaches targeting choroidal/RPE pathways
Some experimental treatments use viral vectors to deliver genes that protect RPE cells or modify choroidal blood-vessel behavior. They are still in pre-clinical or early clinical stages and are not approved treatments for CSR. -
Biologics targeting inflammatory cytokines
New biologic drugs that block specific inflammatory molecules (such as interleukins) are being evaluated in retinal diseases. For CSR, they might eventually help in cases where inflammation plays a strong role, but right now this is research only and not routine.Frontiers -
Platelet-rich plasma (PRP) and growth-factor-based approaches
PRP and growth factors are used experimentally in some eye conditions to boost tissue healing. Their role in CSR is unclear, and any use should be limited to research settings under retina-specialist supervision. -
Systemic immune-modulating drugs in autoimmune or inflammatory settings
When CSR occurs together with systemic inflammatory diseases, immune-modulating treatments (like some biologics or immunosuppressants) may indirectly benefit the eye by calming the whole disease. However, none of these are CSR-specific, and they have serious side effects, so they are only used when clearly indicated for the underlying condition.Frontiers+1 -
Future choroid-targeted therapies
Recent research highlights choroidal thickness, hyperpermeability, and inflammation as key CSR mechanisms, and future drugs may more specifically target these pathways. As of now, they remain in development and are not available for routine CSR care.Wikipedia+2Nature+2
Surgical and Procedural Treatments
These are done by retina specialists, usually for chronic, recurrent, or vision-threatening CSR.
-
Half-dose / half-fluence verteporfin photodynamic therapy (PDT)
PDT is now considered the treatment of choice for chronic CSR. The doctor injects verteporfin into a vein, then shines a low-energy laser on the leaking area in the eye. The activated drug closes abnormal vessels and reduces choroidal leakage, helping fluid to clear and vision to improve. The lower dose/fluence aims to keep benefits while reducing side effects.PMC+2Nature+2 -
Subthreshold / micropulse laser photocoagulation
This laser technique delivers many tiny “micro-bursts” of energy instead of one strong burn, avoiding obvious scars on the retina. It is often used when leaks are away from the very center of vision or when PDT is not available. It aims to stimulate the RPE and reduce fluid leakage with lower risk of visible damage.EyeWiki+2SciSpace+2 -
Conventional focal thermal laser photocoagulation
Older but still useful in selected cases, focal laser directly burns leaking spots outside the foveal center. It can quickly seal leaks, but carries a higher risk of permanent blind spots and is therefore reserved for specific patterns of leakage.PMC+1 -
Intravitreal injection procedures (anti-VEGF, sometimes steroids)
These minimally invasive procedures involve injecting medicine directly into the vitreous cavity. In CSR, they are generally used when there is secondary choroidal neovascularization, or rare cases where other macular complications appear. They are done under sterile conditions in clinic, with close follow-up for infection, pressure spikes, or inflammation.Taylor & Francis Online+1 -
Pars plana vitrectomy and other advanced retinal surgeries
In very complex or atypical cases (for example with traction, epiretinal membrane, or retinal detachment), vitrectomy surgery may be needed to stabilize the retina. This is rare in standard CSR but can be considered if other problems threaten sight and simpler treatments are not enough.Taylor & Francis Online+1
Prevention Tips
-
Keep stress as low as you reasonably can with healthy coping strategies.
-
Maintain good sleep habits and get tested for sleep apnea if you snore heavily or feel very sleepy in the day.
-
Use steroid medicines only when truly needed, at the lowest effective dose, and under close medical supervision.AAO+1
-
Avoid anabolic steroids and unsupervised hormone supplements.MedEdu Journals+1
-
Control blood pressure, blood sugar, and cholesterol with lifestyle and medicines if prescribed.AAO Journal+1
-
Don’t smoke; if you do, ask your doctor for help to quit.Retina Today+1
-
Limit caffeine and energy drinks, especially late at night.Ophthalmology Retina
-
Avoid heavy alcohol use; as a teen, it’s safest to avoid alcohol entirely.Canadian Journal of Ophthalmology+1
-
Have regular eye exams if you have had CSR before, use steroids long-term, or have strong risk factors.NCBI+1
-
Tell all your doctors that you previously had CSR so they think carefully before prescribing strong or long-term steroids.PubMed+2AAO Journal+2
When to See a Doctor
You should see an eye doctor (preferably a retina specialist) as soon as possible if you notice:
-
Sudden blurred or distorted central vision (straight lines look bent or wavy).
-
A dark or gray spot in the center of your vision.
-
Colors look washed-out or different in one eye.
-
Vision in one eye seems smaller or dimmer than the other.
-
Symptoms of CSR that do not improve after 3–4 months.
-
CSR symptoms coming back again and again.NCBI+2AAO+2
Go to emergency care immediately if you have:
-
Sudden flashes, a shower of floaters, or a curtain over your vision (could mean retinal tear or detachment, not CSR).
-
Very painful red eye with vision loss.
What to Eat and What to Avoid
What to eat
-
Leafy green vegetables (spinach, kale, collards) – rich in lutein, zeaxanthin, and other antioxidants for macular health.Frontiers+1
-
Bright-colored fruits and vegetables (carrots, oranges, berries, peppers) – provide vitamins C, E, and carotenoids that support retinal cells.
-
Fatty fish (salmon, sardines, mackerel) 1–2 times per week – good source of omega-3 fatty acids for vessel health.Frontiers
-
Nuts and seeds (almonds, walnuts, sunflower seeds) – supply healthy fats, vitamin E, and minerals.
-
Whole grains (brown rice, oats, whole-wheat bread) – help stabilize blood sugar and support vascular health.
What to avoid or limit
-
Very salty foods (chips, instant noodles, processed meats) – can raise blood pressure and harm blood vessels.AAO Journal+1
-
Sugary drinks and junk foods – they worsen metabolic health and may indirectly harm the retina.
-
Large amounts of caffeine or energy drinks – can increase stress and blood pressure; moderate or avoid especially if you already have CSR.Ophthalmology Retina+1
-
Alcohol, especially heavy or binge drinking – linked with CSR and many other health problems; as a minor, you should avoid it altogether.Canadian Journal of Ophthalmology+1
-
Unregulated body-building supplements or steroid-like products – they can secretly contain steroids or hormone-like substances that trigger CSR.MedEdu Journals+1
Frequently Asked Questions
-
Is central serous retinopathy permanent?
Often, acute CSR goes away by itself and vision improves within months, but chronic or recurrent CSR can cause lasting vision changes if fluid remains under the retina too long. Early diagnosis and follow-up are important.NCBI+1 -
Is CSR caused by stress?
Stress is one of the strongest and most consistent risk factors for CSR. It raises cortisol and adrenaline, which can affect the choroidal vessels under the retina. But usually it’s a mix of stress, steroids, personality traits, and other health factors together.PMC+2AAO Journal+2 -
Can steroid eye drops, creams, or inhalers trigger CSR?
Yes. CSR has been linked to many forms of steroids, including oral tablets, injections, nasal sprays, inhalers, topical creams, and even some eye drops. That’s why doctors are careful with steroid prescriptions in people who have had CSR before.PubMed+2AAO+2 -
Does CSR always need treatment?
No. Many first-time acute cases can be observed if vision is good and the fluid is small. Treatment (usually PDT) is more often used for chronic, recurrent, or visually disabling CSR.NCBI+2PMC+2 -
Which treatment is considered best for chronic CSR?
Current evidence supports half-dose or half-fluence verteporfin PDT as the most effective treatment for chronic CSR, because it reduces choroidal hyperpermeability and helps fluid clear with relatively good safety.Nature+2Wikipedia+2 -
Do pills like eplerenone or spironolactone really work?
Mineralocorticoid receptor antagonists can reduce fluid in some patients, but newer analyses suggest they may offer limited visual benefit overall, and their use is now more cautious. They also have important side effects such as high potassium.Medwave+2Frontiers+2 -
Can CSR come back after it gets better?
Yes. CSR is known for relapses and chronic forms. Risk is higher if triggers like stress or steroids remain. Avoiding triggers and regular monitoring help catch recurrences early.NCBI+2MedEdu Journals+2 -
Can CSR affect both eyes?
CSR usually starts in one eye but can affect both eyes, either at the same time or at different times. Even if symptoms are in one eye, doctors usually check both.NCBI+1 -
Will glasses or contact lenses fix CSR vision?
No. CSR is a retina problem, not a simple focus error. Glasses can correct your basic prescription, but they cannot remove the blur or distortion caused by fluid under the macula.AAO+1 -
Is CSR contagious?
No. CSR is not an infection and cannot spread from person to person. It is related to stress, hormones, blood vessels, and sometimes steroids, not germs.NCBI+1 -
Can I still use a computer or phone if I have CSR?
Yes, but long intense sessions may cause eye strain and make distortion more noticeable. Taking frequent breaks, using good lighting, and enlarging text can help you work or study more comfortably.NCBI+1 -
Can teenagers get CSR?
CSR is most common in adults 30–50, but rarely it can happen in teens, especially if strong risk factors like steroids or extreme stress are present. Because it’s unusual at your age, any visual symptoms should be checked carefully by an eye doctor.ResearchGate+1 -
Does CSR mean I will go blind?
Most people with CSR do not go blind, but some can have lasting central vision changes, especially in chronic or repeatedly relapsing cases. Early diagnosis, avoiding triggers, and appropriate treatment greatly lower the risk of serious vision loss.NCBI+2Wikipedia+2 -
Can healthy food and supplements cure CSR by themselves?
Healthy diet and supplements can support your eyes and overall health, but they cannot replace proven medical treatments when those are needed. Think of them as helpers, not as cures.Frontiers+2Taylor & Francis Online+2 -
What is the most important thing I should do now if I suspect CSR?
The most important step is to see an eye doctor (retina specialist) quickly, tell them all the medicines you use (especially steroids), and follow their plan. Do not start or stop any prescription drug on your own. Early, professional care gives the best chance for your vision to recover safely.NCBI+2AAO+2
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 19, 2025.